Today's Date
Immune System Suppression With Alemtuzumab and Tacrolimus in Liver Transplantation Patients
(
TILT
)
ITN Protocol #:
ITN024ST
Branded Name:
TILT
ClinicalTrials.Gov ID:
NCT00105235Treatment Protocol #:
Campath-1H
Therapeutic Area:
Transplantation
Current Status:
Complete
Summary:
A Phase II Multicenter Trial to Assess the Safety and Efficacy of Campath-1H and Tacrolimus Followed By Immunosuppression Withdrawal in Liver Transplantation
Clinical Operations Manager
Rho Scientist
Study Personnel:
